Patent details

Basic Information

Publication number:

EP2988733

PCT Application Number:

EP2014057883

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP147212567

PCT Publication Number:

WO2014173805

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN

French Title of Invention:

COMPOSITION PHARMACEUTIQUE CONTENANT DU MACITENTAN CRISTALLIN

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT KRISTALLINEM MACITENTAN

SPC Number:

Dates

Filing date:

17/04/2014

Grant date:

27/03/2019

EP Publication Date:

02/03/2016

PCT Publication Date:

30/10/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/03/2019

EP B1 Publication Date:

27/03/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/04/2019

Expiration date:

17/04/2034

Renunciation date:

Revocation date:

18/06/2024

Annulment date:

Owner

From:

20/03/2019

 

 

Name:

Sandoz AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

STEFINOVIC, Marijan

Address:

Austria (AT)

2

Name:

RANEBURGER, Johannes

Address:

Austria (AT)

3

Name:

ENGLMEIER, Ludwig

Address:

Germany (DE)

Priority

Priority Number:

13164724

Priority Date:

22/04/2013

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/20; A61K 31/506;

Publication

European Patent Bulletin

1

Issue number:

201913

Publication date:

27/03/2019

Description:

Grant (B1)

2

Issue number:

202443

Publication date:

23/10/2024

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages